NeuroLogica Corp. develops, manufactures, and markets imaging technologies to healthcare institutions worldwide. The company offers digital radiography systems for hospitals and imaging centers; portable CT imaging systems; and ultrasound imaging systems. It also provides customer support services for various equipment needs, as well as technical support services to solve related issues. The company distributes its products through sales personnel. NeuroLogica Corp. was founded in 2004 and is headquartered in Danvers, Massachusetts. As of January 28, 2013, NeuroLogica Corp. operates as a subsidiary of Samsung Electronics America, Inc.
14 Electronics Avenue
Danvers, MA 01923
Founded in 2004
Samsung NeuroLogica Introduces BodyTom Elite® CT Scanner
Jul 24 17
Samsung NeuroLogica BodyTom®, the world’s first portable, full-body, 32-slice CT (computed tomography) scanner, just got even better. The BodyTom Elite® is the newly upgraded BodyTom, which received FDA 510(k) clearance on June 14, 2017. Incorporating a fresh new visual design, upgraded software, hardware and workstation the BodyTom Elite will make its mark as the go-to premium advanced full-body mobile CT scanner. In the world of advanced imaging, millimeters can be the difference when it comes to delivering an accurate diagnosis or treatment. With this in mind, team of R&D engineers spent the past year designing and improving hardware solutions, such as: Linear and step calibration delivering navigation accuracy for axial and helical scanning. Tilt sensor indicating if there are any significant shifts on the floor. Step Correction feature, which makes automatic adjustments if there are slight movements. New, quieter lift system reducing setup time, aligns with tables easier and allows for faster transition to scanning. New translate system, which pushes the centipede belts to the floor, reducing vibration and thereby improving image accuracy. Significant improvements were also made to the workstation, including: Battery backup, meaning it can be transported without shutting it down, saving time. 2-way patient communication system allowing important information to be conveyed, easing patients as they undergo testing. More processing speed including 32 gigs of RAM and an upgraded processor. More export options including the ability to export datasets to DICOM format and view on PACs. The BodyTom Elite software offers a slew of features, including: Low dose lung cancer screening under 3mGy to detect abnormalities. Contrast capability, which allows use of CT angiography and perfusion imaging utilizing bolus tracking and manual start. Metal Artifact Reduction (MAR) improving metal implants and trauma cases. Intuitive customization, such as the ability to change the slice width and gap, oblique the dataset and render in Maximum Intensity Projection, Minimum Intensity Projection, and Mean Value Projection. Abrand-new noise-reduction algorithm, which will vastly improve image quality. 30 new custom kernels enabling a technologist to choose the sharpness, tissue contrast, and smoothing for each scan type. Automatic exposure control, which minimizes the amount of radiation by factoring the thickness and density of a patient. Wireless access point providing better security and stability of wireless communication by creating a standalone wireless network for the scanner compared to the existing Ad-Hoc environment. BodyTom Elite is XR-29 (MITA Smart Dose) compliant and as such includes four key features of CT equipment that enable optimization or management of radiation dose delivery – dose structured reporting, CT dose check, AEC and pediatric and adult reference protocols. The BodyTom Elite remains a self-shielded, multi-departmental imaging solution capable of transforming any room in the hospital into an advanced imaging suite. The system can accommodate patients of all sizes, and its combination of rapid scan time, flexible settings, and immediate image viewing makes the BodyTom Elite a valuable tool to any facility needing versatile real-time portable imaging.
UC Davis Comprehensive Cancer Center Adopts Samsung NeuroLogica's BodyTom® for Brachytherapy Suite
Apr 20 17
Samsung NeuroLogica announced that the UC Davis Comprehensive Cancer Center in Sacramento, Ca., added BodyTom®, portable, full-body, 32-slice CT scanner to its brachytherapy suite. The BodyTom will significantly improve their workflow process efficiency goals by eliminating the need to transfer patients to a CT simulator room, reducing risks associated with moving patients including displacing brachytherapy applicators and increased duration of brachytherapy procedures. In addition to improving safety, the CT scanner’s real-time imaging enhances accuracy when treating cancer patients undergoing brachytherapy treatment.
Samsung NeuroLogica and MedyMatch Technology Announce Strategic Alliance to Bring A.I. to the Curbside
Mar 29 17
MedyMatch Technology Ltd. and Samsung NeuroLogica Corporation announced a collaboration to integrate artificial intelligence (A.I.) clinical decision support applications with Samsung NeuroLogica's medical imaging hardware in the acute care marketplace. This collaboration will create support tools which provide a second read capability to help caregivers quickly and accurately assess patients in prehospital environments. The first focus area will be in the enhancement of stroke assessment, specifically, with integration of MedyMatch's A.I. technologies into the mobile stroke unit (MSU), a specialized ambulance or other emergency vehicle that is equipped with a Samsung NeuroLogica CereTom® CT (computed tomography) scanner. The mobile unit with diagnostic CT imaging capabilities is designed to allow the team onboard to quickly assess whether a patient is having a stroke caused by a blood clot or hemorrhage. The very first step in patient assessment is to rule out the presence of a brain bleed, and this is where MedyMatch's technology will be utilized pending regulatory approval to provide decision support. The portable X-ray and CT scan device market growth is expected to grow approximately 7.6% CAGR to 2020, reaching $8.41 billion, and MedyMatch is at the forefront of enabling this industry growth.